PubRank

Francois Giuliano

Author PubWeight™ 32.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010 3.55
2 Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003 3.31
3 Apoptosis and effects of intracavernous bone marrow cell injection in a rat model of postprostatectomy erectile dysfunction. Eur Urol 2008 2.38
4 An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE). J Sex Med 2014 1.91
5 International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010 1.60
6 Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J Sex Med 2013 1.53
7 Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2010 1.42
8 Evaluation of erectile function after laparoscopic radical prostatectomy in a single center. Can J Urol 2012 1.38
9 Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 2005 1.36
10 Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011 1.26
11 An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med 2014 1.10
12 Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patients. BJU Int 2010 1.09
13 Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence. Eur Urol 2011 0.94
14 Vardenafil decreases bladder afferent nerve activity in unanesthetized, decerebrate, spinal cord-injured rats. Eur Urol 2010 0.93
15 Lower urinary tract symptoms and sexual health: the role of gender, lifestyle and medical comorbidities. BJU Int 2009 0.86
16 An aryloxypropanolamine hβ3-adrenoceptor agonist as bladder smooth muscle relaxant. Eur J Pharm Sci 2012 0.85
17 SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 2013 0.84
18 Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option. Curr Med Res Opin 2008 0.83
19 Delay of ejaculation induced by SB-277011, a selective dopamine D3 receptor antagonist, in the rat. J Sex Med 2008 0.82
20 Role of the neurokinin-1 receptors in ejaculation in anesthetized rats. J Sex Med 2009 0.79
21 Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat. Am J Physiol Regul Integr Comp Physiol 2013 0.79
22 Brain neuronal activation induced by flibanserin treatment in female rats. Psychopharmacology (Berl) 2013 0.78
23 Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial. J Sex Med 2009 0.77
24 Botulinum neurotoxin A for male lower urinary tract symptoms. Curr Opin Urol 2011 0.76
25 Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis. Can J Urol 2005 0.76